Hepatitis B reactivation from immunosuppressive drug therapy: A global menace
Robert P. Perrillo – 27 March 2015 – Watch a video presentation of this article
Medical interventions associated with HBV reactivation: Common and less common
Justin A. Reynolds, Richard A. Manch, Robert G. Gish – 27 March 2015 – Watch a video presentation of this article
Medical interventions associated with HBV reactivation: Common and less common
Justin A. Reynolds, Richard A. Manch, Robert G. Gish – 27 March 2015 – Watch a video presentation of this article
Liver resection after thermal ablation of parenchymal transection margin using microwave energy
David J. Reich – 27 March 2015 – Watch a video presentation of this article
Defining and grading HBV reactivation
Alissa Visram, Jordan J. Feld – 27 March 2015 – Watch a video presentation of this article
Management strategies for hepatitis B–infected patients undergoing immunomodulatory therapy: Is lamivudine enough?
Norah Terrault – 27 March 2015 – Watch a video presentation of this article
Liver resection after thermal ablation of parenchymal transection margin using microwave energy
David J. Reich – 27 March 2015 – Watch a video presentation of this article
Transplantation speed offers early hepatocyte engraftment in acute liver injured rats: A translational study with clinical implications
Cheng‐Maw Ho, Ya‐Hui Chen, Chin‐Sung Chien, Yi‐Tian Ho, Shu‐Li Ho, Rey‐Heng Hu, Hui‐Ling Chen, Po‐Huang Lee – 26 March 2015 – The impact of the rate of intraportal hepatocyte transplantation on early engraftment and repopulation is unclear. The aim of this study was to address this and to improve the engraftment and repopulation efficiencies of hepatocyte transplantation for the treatment of a rat model of acute liver failure in a clinically useful way without preconditioning. Acute hepatic injury was induced into Sprague‐Dawley rats with D‐galactosamine.
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
Margaret A. Scull, Chao Shi, Ype P. de Jong, Gisa Gerold, Moritz Ries, Markus von Schaewen, Bridget M. Donovan, Rachael N. Labitt, Joshua A. Horwitz, Jenna M. Gaska, Gabriela Hrebikova, Jing W. Xiao, Brenna Flatley, Canny Fung, Luis Chiriboga, Christopher M. Walker, David T. Evans, Charles M. Rice, Alexander Ploss – 26 March 2015 – At least 170 million people are chronically infected with hepatitis C virus (HCV).
Tumor necrosis factor inhibitor therapy for hepatitis B virus–infected individuals: How loud is the alarm bell?
Robert P. Perrillo – 25 March 2015